Document is current
Any future updates will be listed below
-
Authors
Xie, Lu
Xu, Jie
Sun, Xin
Guo, Wei https://orcid.org/0000-0002-4772-6592
Gu, Jin
Liu, Kuisheng
Zheng, Bingxin
Ren, Tingting
Huang, Yi
Tang, Xiaodong
Yan, Taiqiang
Yang, Rongli
Sun, Kunkun
Shen, Danhua
Li, Yuan
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03359018 at ClinicalTrials.govDocuments that mention this clinical trial
Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial
https://doi.org/10.1136/jitc-2020-000798
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81572633)
- License Information
